BioSpace News Archive

G Medical Innovations Holdings Ltd is pleased to report a significant development for the Company with receipt of Emergency Use Authorisation status from the US FDA for the Company’s Vital Signs Monitoring System ECG Patch for the remote monitoring of the QT interval of an ECG in patients who are undergoing treatment in a hospital setting for COVID-19 with drugs that can prolong QT intervals and may cause fatal arrhythmias.

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2020.

Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport”) today announced its intention to offer, subject to market and other conditions, $100.0 million in aggregate principal amount of convertible senior notes due 2025 (

The following statement is attributed to Mindy Brashears, Ph.D., USDA Under Secretary for Food Safety, and Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response. [19-May-2020] SILVER SPRING, Md. , May 19, 2020 /PRNewswire/ -- As the COVID-19 pandemic response continues, the U.S. Department of Agriculture and the U.S. Food and Drug Administration have bee

Multi-Target Collaboration Leverages Vividion’s Screening Platform to Discover and Develop Highly Selective Small Molecules for E3 Ligases and Select Oncology and Immunology Targets

MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics for the treatment of skin conditions, is pleased to announce the appointment of Dr. James Mackay to its Board of Directors.

CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed an investment round of a total 13M euro.

Oxford Immunotec Global PLC, a global, high-growth diagnostics company, announces the release of the T-SPOT Discovery SARS-CoV-2 test kit.

Cipla Limited announced its submission of an Abbreviated New Drug Application for Fluticasone propionate and Salmeterol inhalation powder to the United States Food and Drug Administration.

Invivoscribe to offer the LeukoStrat® CDx FLT3 Mutation Assay as an FDA approved kit with analysis software.